Insys Therapeutics, Inc. a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, announced...
The FDA has approved Epidiolex (cannabidiol) [CBD] oral solution ,from GW Pharma and Greenwich Biosciences, for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older.
Eton Pharmaceuticals, Inc and Azurity Pharmaceuticals, Inc. announced that the FDA has approved Eprontia (topiramate) oral solution, 25mg/mL.
Mirum Pharmaceuticals, Inc. announced that the FDA has approved Livmarli (maralixibat) oral solution for the treatment of cholestatic pruritus in patients five years of age and older with progressive familial intrahepatic cholestasis (PFIC)
Eton Pharmaceuticals, Inc. announced the FDA has accepted for filing the company’s new drug application (NDA) for topiramate oral solution.
Jazz Pharmaceuticals plc announced the publication of the global Phase III double-blind, placebo-controlled, randomized-withdrawal, multicenter study of Xywav (calcium, magnesium, potassium and sodium oxybates) oral solution, for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy.